Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems. CNBC's Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review. https://cnb.cx/3gaWvHI | CNBC

BREAKING: Our FreeStyle Libre 2 system with optional real-time glucose alarms and excellent accuracy now cleared by the FDA for children (4 years) and adults with diabetes. https://abbo.tt/2Y1pVwn Important safety info: abbo.tt/2Ju7BDg | Abbott